Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2013 | 1 |
2014 | 1 |
2016 | 2 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222.
Clin Cancer Res. 2022 Feb 15;28(4):611-617. doi: 10.1158/1078-0432.CCR-21-3131.
Clin Cancer Res. 2022.
PMID: 34844978
Free PMC article.
Clinical Trial.
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408.
Evens AM, Hong F, Habermann TM, Advani RH, Gascoyne RD, Witzig TE, Quon A, Ranheim EA, Ansell SM, Cheema PS, Dy PA, O'Brien TE, Winter JN, Cescon TP, Chang JE, Kahl BS.
Evens AM, et al. Among authors: dy pa.
Clin Cancer Res. 2020 Sep 1;26(17):4468-4477. doi: 10.1158/1078-0432.CCR-20-1345. Epub 2020 Jun 12.
Clin Cancer Res. 2020.
PMID: 32532790
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622.
Schott AF, Barlow WE, Van Poznak CH, Hayes DF, Moinpour CM, Lew DL, Dy PA, Keller ET, Keller JM, Hortobagyi GN.
Schott AF, et al. Among authors: dy pa.
Breast Cancer Res Treat. 2016 Aug;159(1):87-95. doi: 10.1007/s10549-016-3911-z. Epub 2016 Jul 30.
Breast Cancer Res Treat. 2016.
PMID: 27475087
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.
Jain N, Curran E, Iyengar NM, Diaz-Flores E, Kunnavakkam R, Popplewell L, Kirschbaum MH, Karrison T, Erba HP, Green M, Poire X, Koval G, Shannon K, Reddy PL, Joseph L, Atallah EL, Dy P, Thomas SP, Smith SE, Doyle LA, Stadler WM, Larson RA, Stock W, Odenike O.
Jain N, et al. Among authors: dy p.
Clin Cancer Res. 2014 Jan 15;20(2):490-8. doi: 10.1158/1078-0432.CCR-13-1311. Epub 2013 Oct 31.
Clin Cancer Res. 2014.
PMID: 24178622
Free PMC article.
Clinical Trial.
Item in Clipboard
Resilience and Disaster Trends in the Philippines: Opportunities for National and Local Capacity Building.
Alcayna T, Bollettino V, Dy P, Vinck P.
Alcayna T, et al. Among authors: dy p.
PLoS Curr. 2016 Sep 14;8:ecurrents.dis.4a0bc960866e53bd6357ac135d740846. doi: 10.1371/currents.dis.4a0bc960866e53bd6357ac135d740846.
PLoS Curr. 2016.
PMID: 27790382
Free PMC article.
Item in Clipboard
Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
Rastogi P, Buyse ME, Swain SM, Jacobs SA, Robidoux A, Liepman MK, Pajon ER, Dy PA, Posada JG Jr, Melnik MK, Piette F, Geyer CE Jr, Mamounas EP, Wolmark N.
Rastogi P, et al. Among authors: dy pa.
Clin Breast Cancer. 2011 Aug;11(4):228-34. doi: 10.1016/j.clbc.2011.04.001. Epub 2011 May 4.
Clin Breast Cancer. 2011.
PMID: 21684812
Clinical Trial.
Item in Clipboard
Cite
Cite